205 related articles for article (PubMed ID: 16830219)
1. Modifier effect of the Toll-like receptor 4 D299G polymorphism in children with cystic fibrosis.
Urquhart DS; Allen J; Elrayess M; Fidler K; Klein N; Jaffé A
Arch Immunol Ther Exp (Warsz); 2006; 54(4):271-6. PubMed ID: 16830219
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice.
Canale-Zambrano JC; Auger ML; Haston CK
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G381-90. PubMed ID: 20522639
[TBL] [Abstract][Full Text] [Related]
3. Familial concordance of phenotype and microbial variation among siblings with CF.
Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
[TBL] [Abstract][Full Text] [Related]
4. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
[TBL] [Abstract][Full Text] [Related]
5. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
6. ENaCbeta and gamma genes as modifier genes in cystic fibrosis.
Viel M; Leroy C; Hubert D; Fajac I; Bienvenu T
J Cyst Fibros; 2008 Jan; 7(1):23-9. PubMed ID: 17560176
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
8. Disease modifying genes in cystic fibrosis.
Slieker MG; Sanders EA; Rijkers GT; Ruven HJ; van der Ent CK
J Cyst Fibros; 2005 Aug; 4 Suppl 2():7-13. PubMed ID: 15996905
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 variants reduce airway response in human subjects at high endotoxin levels in a swine facility.
Senthilselvan A; Dosman JA; Chénard L; Burch LH; Predicala BZ; Sorowski R; Schneberger D; Hurst T; Kirychuk S; Gerdts V; Cormier Y; Rennie DC; Schwartz DA
J Allergy Clin Immunol; 2009 May; 123(5):1034-40, 1040.e1-2. PubMed ID: 19368968
[TBL] [Abstract][Full Text] [Related]
10. Aquagenic wrinkling of the palms in cystic fibrosis: comparison with controls and genotype-phenotype correlations.
Berk DR; Ciliberto HM; Sweet SC; Ferkol TW; Bayliss SJ
Arch Dermatol; 2009 Nov; 145(11):1296-9. PubMed ID: 19917960
[TBL] [Abstract][Full Text] [Related]
11. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
12. Association of improved pulmonary phenotype in Irish cystic fibrosis patients with a 3' enhancer polymorphism in alpha-1-antitrypsin.
Courtney JM; Plant BJ; Morgan K; Rendall J; Gallagher C; Ennis M; Kalsheker N; Elborn S; O'Connor CM
Pediatr Pulmonol; 2006 Jun; 41(6):584-91. PubMed ID: 16617455
[TBL] [Abstract][Full Text] [Related]
13. Modifier genes in cystic fibrosis lung disease.
Merlo CA; Boyle MP
J Lab Clin Med; 2003 Apr; 141(4):237-41. PubMed ID: 12677168
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection.
Park JE; Yung R; Stefanowicz D; Shumansky K; Akhabir L; Durie PR; Corey M; Zielenski J; Dorfman R; Daley D; Sandford AJ
Genes Immun; 2011 Jul; 12(5):370-7. PubMed ID: 21270830
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
Duguépéroux I; De Braekeleer M;
J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
[TBL] [Abstract][Full Text] [Related]
16. Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype.
Yarden J; Radojkovic D; De Boeck K; Macek M; Zemkova D; Vavrova V; Vlietinck R; Cassiman JJ; Cuppens H
Thorax; 2005 Apr; 60(4):320-5. PubMed ID: 15790988
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary infection in mild variant cystic fibrosis: implications for care.
Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
[TBL] [Abstract][Full Text] [Related]
20. Modifier genes in cystic fibrosis.
Davies JC; Griesenbach U; Alton E
Pediatr Pulmonol; 2005 May; 39(5):383-91. PubMed ID: 15765543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
